199 related articles for article (PubMed ID: 15562904)
1. Elevated expression of cyclooxygenase-2 in adenocarcinoma of the parotid gland: insights into malignant transformation of pleomorphic adenoma.
Sakamoto T; Kondo K; Yamasoba T; Sugasawa M; Kaga K
Ann Otol Rhinol Laryngol; 2004 Nov; 113(11):930-5. PubMed ID: 15562904
[TBL] [Abstract][Full Text] [Related]
2. Expression of cyclooxygenase-2, Bcl-2 and Ki-67 in pleomorphic adenoma with special reference to tumor proliferation and apoptosis.
Aoki T; Tsukinoki K; Karakida K; Ota Y; Otsuru M; Kaneko A
Oral Oncol; 2004 Oct; 40(9):954-9. PubMed ID: 15380175
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of cyclooxygenase-2 and Ki-67 are associated with malignant transformation of pleomorphic adenoma.
Katori H; Nozawa A; Tsukuda M
Auris Nasus Larynx; 2007 Mar; 34(1):79-84. PubMed ID: 17049779
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 regulates the degree of apoptosis by modulating bcl-2 protein in pleomorphic adenoma and mucoepidermoid carcinoma of the parotid gland.
Sakamoto T; Uozaki H; Kondo K; Imauchi Y; Yamasoba T; Sugasawa M; Kaga K
Acta Otolaryngol; 2005 Feb; 125(2):191-5. PubMed ID: 15880952
[TBL] [Abstract][Full Text] [Related]
5. Expression of estrogen receptor, progesterone receptor, and insulin-like growth factor receptor-1 and of MIB-1 in patients with recurrent pleomorphic adenoma of the parotid gland.
Glas AS; Hollema H; Nap RE; Plukker JT
Cancer; 2002 Apr; 94(8):2211-6. PubMed ID: 12001119
[TBL] [Abstract][Full Text] [Related]
6. The role of Nrf2 in pathology of pleomorphic adenoma in parotid gland.
Droździk A; Kowalczyk R; Jaworowska E; Urasińska E; Kurzawski M
Med Sci Monit; 2015 Apr; 21():1243-8. PubMed ID: 25928388
[TBL] [Abstract][Full Text] [Related]
7. S100P expression in ductal type of carcinoma ex pleomorphic adenoma.
Hashimoto K; Yamamoto H; Shiratsuchi H; Nakashima T; Tamiya S; Higaki Y; Komune S; Tsuneyoshi M; Oda Y
Am J Surg Pathol; 2011 Mar; 35(3):346-55. PubMed ID: 21317706
[TBL] [Abstract][Full Text] [Related]
8. The role of the p53 gene in the malignant transformation of pleomorphic adenomas of the parotid gland.
Righi PD; Li YQ; Deutsch M; McDonald JS; Wilson KM; Bejarano P; Stambrook PJ; Osterhage D; Nguyen C; Gluckman JL
Anticancer Res; 1994; 14(5B):2253-7. PubMed ID: 7840532
[TBL] [Abstract][Full Text] [Related]
9. Study of histopathological, morphological and immunohistochemical features of recurrent pleomorphic adenoma: an attempt to predict recurrence of pleomorphic adenoma.
Soares AB; Altemani A; de Araújo VC
J Oral Pathol Med; 2011 Apr; 40(4):352-8. PubMed ID: 20969626
[TBL] [Abstract][Full Text] [Related]
10. The role of aryl hydrocarbon receptor (AhR) in the pathology of pleomorphic adenoma in parotid gland.
Drozdzik A; Kowalczyk R; Lipski M; Łapczuk J; Urasinska E; Kurzawski M
Arch Oral Biol; 2016 Jan; 61():53-9. PubMed ID: 26513682
[TBL] [Abstract][Full Text] [Related]
11. Benign metastasizing pleomorphic adenoma of the parotid gland: a clinicopathologic puzzle.
Marioni G; Marino F; Stramare R; Marchese-Ragona R; Staffieri A
Head Neck; 2003 Dec; 25(12):1071-6. PubMed ID: 14648866
[TBL] [Abstract][Full Text] [Related]
12. Pleomorphic adenoma of the parotid gland 1985-2010: A Danish nationwide study of incidence, recurrence rate, and malignant transformation.
Andreasen S; Therkildsen MH; Bjørndal K; Homøe P
Head Neck; 2016 Apr; 38 Suppl 1():E1364-9. PubMed ID: 26382619
[TBL] [Abstract][Full Text] [Related]
13. Giant pleomorphic adenoma of the parotid gland with malignant transformation.
Honda T; Yamamoto Y; Isago T; Nakazawa H; Nozaki M; Hirayama T
Ann Plast Surg; 2005 Nov; 55(5):524-7. PubMed ID: 16258307
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 and p16 expression in pleomorphic adenoma and carcinoma ex pleomorphic adenoma of the parotid gland.
Patel RS; Rose B; Bawdon H; Hong A; Lee CS; Fredericks S; Gao K; O'Brien CJ
Histopathology; 2007 Nov; 51(5):691-6. PubMed ID: 17927591
[TBL] [Abstract][Full Text] [Related]
15. Expression of c-erbB-2 protein detected in adenocarcinoma arising from parotid pleomorphic adenoma.
Sugawara K; Mori S; Morita M
Auris Nasus Larynx; 1990; 17(2):115-20. PubMed ID: 1977376
[TBL] [Abstract][Full Text] [Related]
16. Recurrent pleomorphic adenoma of the parotid gland: a prospective histopathological and immunohistochemical study.
Stennert E; Wittekindt C; Klussmann JP; Arnold G; Guntinas-Lichius O
Laryngoscope; 2004 Jan; 114(1):158-63. PubMed ID: 14710014
[TBL] [Abstract][Full Text] [Related]
17. [Recurring tumors of the parotid gland with special reference to pleomorphic adenoma].
Ott PM; Grob U
Schweiz Med Wochenschr; 1982 May; 112(21):757-60. PubMed ID: 6285455
[TBL] [Abstract][Full Text] [Related]
18. [Recurrent benign tumors of the parotid gland and their tendency for becoming malignant].
Mann W; Beck C; Karatay MC
Laryngol Rhinol Otol (Stuttg); 1985 Mar; 64(3):133-5. PubMed ID: 2985894
[TBL] [Abstract][Full Text] [Related]
19. Cyclin A expression and its diagnostic value in pleomorphic adenoma and carcinoma expleomorphic adenoma of the parotid gland.
Patel RS; Hughes CW; Fredericks S; Lee CS; Rose B; Gao K; Smith G; Hong A; O'Brien CJ
Histopathology; 2007 Jul; 51(1):21-5. PubMed ID: 17593077
[TBL] [Abstract][Full Text] [Related]
20. Recurrent pleomorphic adenoma of the parotid gland: A population-based study with emphasis on re-recurrence and malignant transformation.
Xu W; Zhang X; Wu Y; Zhu Y; Liu S; Lu H; Yang W
Head Neck; 2023 Mar; 45(3):697-705. PubMed ID: 36563305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
